Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Mallinckrodt PLC

+ Add to Watchlist

MNK:US

127.1800 USD 1.6300 1.27%

As of 20:04:05 ET on 05/22/2015.

Company Profile for Mallinckrodt PLC (MNK)

Mallinckrodt PLC develops, manufactures and markets specialty pharmaceutical products and diagnostic imaging agents. The Company specializes in the manufacturing of pain management medications. Mallinckrodt offers its products to major wholesalers and retail drug store chains around the world.

Contact Information

Mallinckrodt PLC

675 McDonnell Blvd
St Louis, MO 63042
United States
Phone: 1-314-654-2000

Key Executives for Mallinckrodt PLC (MNK)

Mark C TrudeauPresident/CEOMatthew K HarbaughSenior VP/CFO
Raymond FureySenior VP/Chief Compliance OfcrMario SaltarelliSenior VP/Chief Science Ofcr
Ian J WatkinsSenior VP/Chief Human Resource OfcrGary M PhillipsSenior VP/Pres:Autoimmune
Hugh O'NeillSenior VP/Pres:US Spec PharmPeter G EdwardsSenior VP/General Counsel
Meredith FischerSenior VP:CommunicationsFrank ScholzSenior VP:Global Operations
Sandra HattenSenior VP:Quality & RegulatoryJohn E EinwalterVP/Treasurer
John MotenVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil